EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Risk and timing of isotretinoin‐related laboratory disturbances: a population‐based study

Shirin Emtenani, Mariam Abdelghaffar iD, Ralf J Ludwig, Enno Schmidt, Khalaf Kridin iD

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17225 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Shirin Emtenani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Isotretinoin, Acne Vulgaris, Dermatologic Agents, Aspartate Aminotransferases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Uncertainty surrounds the optimal routine laboratory monitoring in acne patients treated with isotretinoin.

Objective

Our aim was to evaluate the risk of mild and severe laboratory abnormalities in patients with acne starting isotretinoin versus oral antibiotic treatment.

Methods

A global population‐based retrospective cohort study assigned two groups of patients with acne‐prescribed isotretinoin ( n = 79,012) and oral antibiotics ( n = 79,012). Comprehensive propensity‐score matching was conducted.

Results

Compared to acne patients treated with oral antibiotics, those under isotretinoin demonstrated an increased risk of grade ≥3 hypertriglyceridemia (hazard ratio [HR], 7.85; 95% confidence interval [CI], 5.58–11.05; P < 0.001) and grade ≥3 elevated aspartate transaminase (AST) levels (HR, 1.45; 95% CI, 1.13–1.85; P = 0.003) within the initial 3 months of treatment. The absolute risk of these abnormalities among isotretinoin initiators was 0.4% and 0.2%, respectively. The risk difference of these findings was clinically marginal: 3 and 1 additional cases per 1,000 patients starting isotretinoin, respectively. There was no significant risk of grade ≥3 impairment in cholesterol, alanine transaminase, gamma‐glutamyl transferase, or creatinine levels under isotretinoin. Most laboratory abnormalities were documented 1–3 months after drug initiation in time‐stratified analysis.

Conclusion

Isotretinoin is associated with a clinically marginal increased risk of severe hypertriglyceridemia and hypertransaminasemia. Routine blood testing should be performed 1–3 months after commencing therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinAcne VulgarisDermatologic AgentsAspartate AminotransferasesHypertriglyceridemiaAlanine TransaminaseAnti-Bacterial AgentsHumansMaleRetrospective StudiesFemaleYoung AdultAdolescentAdultTime Factorsgamma-GlutamyltransferaseAdministration, OralCholesterolCreatinine

Stichwörter der Autor:innen

acneisotretinoinlaboratory abnormalitieslaboratory disturbancesoral antibiotics

Substanzen

IsotretinoinDermatologic AgentsAspartate AminotransferasesAlanine TransaminaseAnti-Bacterial Agentsgamma-GlutamyltransferaseCholesterolCreatinine

Autor:innen und Institutionen

  • Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • School of Medicine, Royal College of Surgeons in Ireland, Manama, Bahrain.
  • Department of Dermatology, University Hospital of Schleswig Holstein (UKSH), Campus Lübeck, Lübeck, Germany.

ORCID-Profile: Mariam Abdelghaffar, Khalaf Kridin

Zitieren

APA

Emtenani, S., Abdelghaffar, M., Ludwig, R. J., Schmidt, E., & Kridin, K. (2024). Risk and timing of isotretinoin‐related laboratory disturbances: a population‐based study. International Journal of Dermatology. https://doi.org/10.1111/ijd.17225

Vancouver

Emtenani S, Abdelghaffar M, Ludwig RJ, Schmidt E, Kridin K. Risk and timing of isotretinoin‐related laboratory disturbances: a population‐based study. International Journal of Dermatology. 2024. doi:10.1111/ijd.17225

BibTeX
@article{Emtenani2024,
  author = {Emtenani, Shirin and Abdelghaffar, Mariam and Ludwig, Ralf J and Schmidt, Enno and Kridin, Khalaf},
  title = {Risk and timing of isotretinoin‐related laboratory disturbances: a population‐based study},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17225}
}
Kostenlos starten →